These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36063578)

  • 1. Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry.
    Sota J; Vitale A; Lopalco G; Pereira RMR; Giordano HF; Antonelli IPB; Makowska J; Brzezińska O; Lewandowska-Polak A; Ruscitti P; Cipriani P; Cola ID; Govoni M; Ruffili F; Sfikakis PP; Laskari K; Ragab G; Hussein MA; Gentileschi S; Gaggiano C; La Torre F; Maier A; Emmi G; Marino A; Ciccia F; Sfriso P; Maggio MC; Bartoloni E; Lomater C; Hegazy MT; Tektonidou M; Dagostin MA; Opinc A; Sebastiani GD; Giacomelli R; Giudice ED; Olivieri AN; Tufan A; Kardas RK; Nuzzolese R; Cardinale F; Więsik-Szewczyk E; Veronica P; Tarsia M; Iannone F; Della Casa F; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L
    Semin Arthritis Rheum; 2022 Dec; 57():152089. PubMed ID: 36063578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.
    Tang KT; Hsieh CW; Chen HH; Chen YM; Chang SH; Huang PH; Lan JL; Chen DY
    Clin Rheumatol; 2022 Feb; 41(2):557-566. PubMed ID: 34535869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
    Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
    Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis.
    Ma Y; Wu M; Zhang X; Xia Q; Yang J; Xu S; Pan F
    Mod Rheumatol; 2018 Sep; 28(5):849-857. PubMed ID: 29251027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.
    Cipriani P; Ruscitti P; Carubbi F; Pantano I; Liakouli V; Berardicurti O; Giacomelli R
    Clin Rheumatol; 2014 Jan; 33(1):49-55. PubMed ID: 24005839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
    Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
    Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-onset still's disease and treatment results with tocilizumab.
    Kır S; Özgen M; Zontul S
    Int J Clin Pract; 2021 Mar; 75(3):e13936. PubMed ID: 33332679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
    Park EH; Lee EY; Shin K; Kim HA
    Rheumatol Int; 2020 May; 40(5):791-798. PubMed ID: 31598752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
    Sakai R; Nagasawa H; Nishi E; Okuyama A; Takei H; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Ito T; Kameda H; Takeuchi T; Amano K
    Clin Rheumatol; 2012 Mar; 31(3):569-74. PubMed ID: 22215118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
    Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Suzuki S; Kataoka Y; Otani T; Taniguchi Y; Ikeda K; Tamura N; Morimoto S
    Clin Rheumatol; 2024 Mar; 43(3):1245-1251. PubMed ID: 38342797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab in adult-onset Still's disease: the Israeli experience.
    Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
    J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.
    Nishina N; Kaneko Y; Kameda H; Takeuchi T
    Mod Rheumatol; 2015 May; 25(3):401-4. PubMed ID: 25401229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.
    Sun Z; Li R; Wang Y; Han F; Wei W; Li X
    Drugs R D; 2023 Jun; 23(2):109-120. PubMed ID: 37010773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab.
    Imaizumi C; Saito M; Abe F; Kaga H; Saito A; Nara M; Kameyama S; Miura H; Ogasawara H; Hirakawa T; Mizunuma M; Satoh M; Komatsuda A; Terada Y; Takahashi N
    Intern Med; 2022 Oct; 61(20):3137-3140. PubMed ID: 35283384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of biological agents in adult-onset Still's disease.
    Cavalli G; Franchini S; Aiello P; Guglielmi B; Berti A; Campochiaro C; Sabbadini MG; Baldissera E; Dagna L
    Scand J Rheumatol; 2015; 44(4):309-14. PubMed ID: 25656459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.
    Vitale A; Cavalli G; Colafrancesco S; Priori R; Valesini G; Argolini LM; Baldissera E; Bartoloni E; Cammelli D; Canestrari G; Sota J; Cavallaro E; Massaro MG; Ruscitti P; Cipriani P; De Marchi G; De Vita S; Emmi G; Ferraccioli G; Frassi M; Gerli R; Gremese E; Iannone F; Lapadula G; Lopalco G; Manna R; Mathieu A; Montecucco C; Mosca M; Piazza I; Piga M; Pontikaki I; Romano M; Rossi S; Rossini M; Silvestri E; Stagnaro C; Talarico R; Tincani A; Viapiana O; Vitiello G; Galozzi P; Sfriso P; Gaggiano C; Rigante D; Dagna L; Giacomelli R; Cantarini L
    Front Pharmacol; 2019; 10():296. PubMed ID: 31001115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.